SYDNEY COHEN
From the Department of Chemical Pathology, Guy's Hospital Medical School, London A consideration of the overall properties of antibodies has for some time suggested that their structural features must be unique among protein molecules. In the first place, serum antibodies within a species share a variety of physical, chemical and antigenic properties indicating that all have a common basic structure. However, the immunoglobulins of all animal species investigated occur in several forms, somewhat arbitrarily designated as classes, subclasses, or types, and distinguished on the basis of their chemical and biological properties. In addition, the great diversity of antigens which evoke an immune response and the narrowly defined specificity of the serum antibodies formed indicate that each individual can synthesize a very large number of antibodies-probably more than 105-and there is conclusive evidence that these differ from one another in their covalent structure. The fundamental problem of antibody structure therefore concerns the nature of the molecular modifications which are superimposed upon a relatively constant basic configuration to generate a finite number of immunoglobulin classes and a very large assortment of distinct combining specificities. The extent to which this problem has been elucidated by studies of protein structure is outlined in this paper. It has been reviewed by Leslie and Cohen (1973) .
There is an additional intriguing problem which concerns the way that antibodies mediate complex biological reactions including, for example, the expression of acquired protective immunity or immediate hypersensitivity. There are very few instances in which the interaction of antigen with antibody leads directly to biological effects. Such primary reactions are limited to the inactivation of enzymes and toxins and the neutralization of some viruses and protozoa. In the great majority of cases the biological expression of immune reactivity requires interaction of antibody with either the complement system or with specific cell surfaces. Such reactions involve specific effector sites on the antibodies which are distributed unevenly among the classes and subclasses of immunoglobulin. These sites are involved in complement-or cell-mediated lysis, opsonization by macrophages and mast cell 1 degranulation resulting in immediate hypersensitivity. None of these reactions is mediated by antibody alone but all can be initiated by the combination of antibody with antigen. How do antigens trigger these events and can their effects be explained in terms of a structural modification of antibody molecules?
Structure of Immunoglobulins (Ig)
The four-chain structure of Ig, consisting of two heavy and two light chains covalently linked by interchain disulphide bonds (fig 1) IgA, consist of polymers of the four-chain unit linked by a J-chain, which is rich in half-cysteine residues and common to both classes. Antibodies of all classes have light chains of two types (K or A).
Certain features of this structure are of particular significance in regard to the generation of antibody specificity and the properties of immunoglobulin effector sites.
Ig chains contain an N-terminal variable region (V) comprising about 120 amino acid residues in which all heterogeneity within a subclass is localized. This was demonstrated first by Hilschmann and Craig in 1965 for human K-chains, but V-regions of similar extent occur on all light and heavy chains.
The remaining C-terminal portions (C) of Ig chains within a given subclass have, by contrast, an invariant structure apart from differences attributable to individual genotypes. The complete sequence of a human yl-chain was elucidated by Edelman (1971) Spiegelberg, 1974) .
The heavy chain region which contains the Cys residues involved in interchain disulphide bonding shows considerable variation between classes and subclasses and no homology with other sections of the heavy or light chain. This stretch of the y-and o-chain is rich in proline and is susceptible to proteolysis. This section, on the basis of electron micrography and other physical measurements, has been designated the hinge region (fig 1) but the extent to which the Fab arms can move relative to one another remains uncertain (Metzger, 1974 The size of the antibody-combining sites, assessed by determining the dimensions of antigenic determinants which give optimum binding, has been estimated as 3.4 nm x 1-7 nm x 0.6 nm. This indicates that 10 to 20 amino acids comprise the combining site and make direct contact with the antigenic determinant. Electron microscopy of antibodies complexed with a divalent hapten indicates that the binding site is situated at the extreme ends of the Fab regions and has a maximum depth of about 4.0 nm.
In general, antibodies react most strongly with the antigen which elicited their synthesis and show graded affinities for structurally related compounds. Stereo-complementarity of the antigenic determinant and the antibody-combining site is thought to provide the major contribution to the non-covalent associations which determine specificity. It is therefore surprising that high affinity antibodies may show strong cross reactions with haptens of quite distinct structure. This suggests that whereas weak hydrophobic interactions between antigen and a closely fitting antibody site may be predominant in low affinity antibodies, additional stronger forces with less stereospecificity may operate in high affinity antibodies; their nature would presumably vary with the chemical identity of functional groups in the antigenic determinant. Another explanation of unexpected cross specificities is that the antibody cavity may contain more than one binding site and that distinct small haptens might adhere to separate sites on opposite walls of the cavity, and that steric hindrance accounts for competitive inhibition of one hapten by the other.
Direct evidence that antibody specificity is determined by amino acid sequence arose from a study in which complete reduction and unfolding of Fab fragments produced concomitant loss of antibody activity, while removal of the denaturant was associated with significant recovery ofthe original activity. This indicates that the chain folding which generates combining specificity is dependent on the primary sequence of the Fab fragments. The presence of variable sequences confined to the Nterminal portions of Fab fragments again suggested that primary structure generates combining specificities. Analysis of the variable sequences in antibodies of defined specificity has been hampered by the heterogeneity of most purified antibodies raised against even the simplest hapten and also by the rarity of myeloma proteins having specific binding affinities within the range for elicited antibodies. Comparative sequence studies on monoclonal 3 proteins have revealed, within the V-regions of both heavy and light chains, three short stretches with high sequence variability (Wu and Kabat, 1970 (Poljak, Amzel, Avey, Chen, Phizackerley, and Saul, 1973) . Further studies have revealed that a hapten having specific affinity for this Fab fragment is indeed bound in the shallow groove between heavy and light chains and appears to be in contact with segments of the Ig sequence which contain the hypervariable regions (Amzel, Poljak, Saul, Varga, and Richards, 1974 is a fragment produced by pepsin which splits the molecule on the C-terminal side of the interheavy chain disulphide bridge (see fig 1) . When the latter is also split two Fab' fragments result. 'The subclass of IgG containing y, heavy chains (see table I ). 'One of the three subunits of the first component of complement, Cl.
terminal Fc' fragment is inactive in this regard. The Fc fragment of human IgA has not been isolated, but mouse and rabbit IgA Fc can be prepared and, from the latter species, binds the secretory component characteristically associated with seromucous IgA.
The failure to isolate active fragments from the Fc portions of Ig molecules has meant that the structure of the effector sites remains obscure. The IgG sites which react with Clq and bind to macrophages and the IgE sites which attach to mast cells are all inactivated by mild reduction suggesting that integrity of interheavy chain disulphide bonds in the hinge region is essential. In the case of antigen attached to cell surfaces, the interaction with Cl by two adjacent IgG molecules fixed to the cell antigens is sufficient to initiate the full cycle of lysis. Antigen density on the cell surface is therefore a critical factor in determining the occurrence of complement-mediated cytotoxic reactions (fig 4) . Thus, the non-lytic nature of anti-Rh antibodies is attributed to the comparative paucity of D antigen sites on the erythrocyte surface. Similarly, the adsorption of host components onto cell surfaces may alter the antigen density of established tumours and parasites and permit evasion of complementmediated cytolysis, which nevertheless remains effective against homologous cells newly introduced into the host-a phenomenon referred to as concomitant immunity. Mast cells have homocytotrophic antibodies (IgE) bound to their surface membranes ( fig 5A) but are triggered for histamine release only after the bound molecules have become cross linked, usually by polyvalent antigen (fig SB) . By contrast, the majority of monovalent haptens are totally ineffective ( fig SD) . The requirement for cross linking implies that the density of cell-bound IgE of given specificity is a critical factor determining antigen-induced hyper- (Metzger, 1974; Leslie and Cohen, 1973 Ig to which they belong. This functional dualism is generated by peptide chains which are unique in having variable N-terminal (V) regions and constant C-terminal (C) regions.
The two antigen-binding sites of each four-chain Ig molecule are contained within the V-regions of both heavy and light chains. Specificity is determined by primary structure. X-ray diffraction studies show that combining sites are generated by the short hypervariable stretches in heavy and light chains. The stereochemical configuration of the antibody site is regarded as the prime determinant of specificity. Biological effector sites occur predominantly in the Fc portion of the molecule which comprises the two C-terminal intrachain disulphide loops of the heavy chains. Little information is available about the location, chemical structure, specificity, or affinity of these sites. All appear accessible in native Ig and some, including those responsible for placental and gastrointestinal transfer of Ig molecules and for the concentration-dependent control of lgG catabolic rate, are active in free molecules. Other effector sites are present on free Ig molecules and interact with their relevant receptors, but the full biological sequence is initiated only after the bound antibody has become cross linked, usually by polyvalent antigen. This is true for complement activation, IgE-mediated hypersensitivity and possibly also for opsonin-induced phagocytosis.
The cross linkage of Ig leads to lattice formation and this may trigger the biological sequence by producing aggregation or conformational change in the receptor. An Ig lattice signal is consistent with the known presence of effector sites on native Ig molecules, the failure of monovalent or excess polyvalent antigen to induce reactions, and the triggering which occurs with diverse forms of cross linking. Ig conformational changes may have a role in initiating biological reactions, but their occurrence does not seem mandatory.
